Showing results (231-240 of 310) with videos related to
Sort By:
Pageof 31
The Australian and New Zealand Journal of Psychiatry|September 1, 1991
The prevalence of psychiatric morbidity in general hospital inpatientsD M Clarke, I H Minas, G W StuartExperientia. Supplementum|January 1, 1987
Metal regulatory elements of the mouse metallothionein-I geneP F Searle, G W Stuart, R D PalmiterNature|October 6, 1985
Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequencesG W Stuart, P F Searle, R D PalmiterArchives of Psychiatric Nursing|June 1, 1989
Behavioral treatment of panic-related disorders: a reviewM T Laraia, G W Stuart, C L BestThe Australian and New Zealand Journal of Psychiatry|June 1, 1991
Concordance with recommendations in a consultation-liaison psychiatry serviceL N Seward, G C Smith, G W StuartBiochemical Pharmacology|March 29, 2001
Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant miceC Zaccaro, S Sweitzer, S Pipino, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Marked increases in hepatic NAD(P)H:oxidoreductase gene transcription and mRNA levels correlated with a mouse chromosome 7 deletionD D Petersen, F J Gonzalez, V Rapic, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 2, 2002
Assessing the evidence on case managementS J Ziguras, G W Stuart, A C JacksonComprehensive Psychiatry|November 1, 1988
The development, use, and reliability of the brief psychiatric rating scale (nursing modification)--an assessment procedure for the nursing team in clinical and research settingsP D McGorry, R J Goodwin, G W StuartToxicology and Applied Pharmacology|January 6, 1999
Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null miceR P Tonge, E J Kelly, S A Bruschi, et al.Pageof 31